ID   PSFDFN388
AC   CVCL_YU45
DR   Wikidata; Q98128677
RX   PubMed=27920058;
WW   https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27920058
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 15
ST   D21S11: 30,33.2
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 20,21
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y1M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27920058; DOI=10.1136/jmedgenet-2016-104295; PMCID=PMC5384422;
RA   Bar D.Z., Arlt M.F., Brazier J.F., Norris W.E., Campbell S.E.,
RA   Chines P.S., Larrieu D., Jackson S.P., Collins F.S., Glover T.W.,
RA   Gordon L.B.;
RT   "A novel somatic mutation achieves partial rescue in a child with
RT   Hutchinson-Gilford progeria syndrome.";
RL   J. Med. Genet. 54:212-216(2017).
//